HIGHLIGHTS
SUMMARY
The authors applied the method to IBD, a group of intestinal disorders characterized by chronic inflammation of the gastrointestinal tract and imbalances between microbes and immune systems (Schirmer et_al, 2018b; Lloyd-Price et_al, 2019). The authors selected the samples without using antibiotics provided in Lewis et_al, 2015 (available at NCBI SRA, accession number: SRP057027) to construct the validation set "Val_Lewis", resulting in 99 samples of 31 CD patients in total and up to 4 samples for each subject. Although healthy control samples were provided in Lewis et_al, 2015 as well, they were one-visit . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.